LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice

Starting soon

Conditions studied: Psoriasis, Atopic Dermatitis, Vitiligo, Alopecia Areata, Hidradenitis Suppurativa

In brief

This multicenter retrospective observational registry study will collect existing clinical data from Italian centers to describe epidemiology, treatment patterns, clinical evolution, safety, and comorbidities in patients aged 12 years and older with psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa.

Key facts

Study ID

NCT07336641

Run by

Fondazione ISIDE

People needed

20000

Starts

2026-01-01

Expected to finish

2028-01-01

Last updated by the study team

2026-01-15

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Documented diagnosis of psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa.
• Age 12 years or older at the first recorded visit.
• Eligible for or treated with systemic therapies.
• At least one documented visit during January 2016 to December 2025.
• No opt-out exercised.

You may not qualify if…

• Opt-out exercised.
• Medical records with insufficient data.

Where it is running

• IRCCS Istituto Clinico Humanitas - Dermatology Unit — Rozzano, Lombardy, Italy

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.